Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Cell and Developmental Biology|April 10, 2023
CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspectiveFiona H Zhou, Teesha Downton, Allegra Freelander, et al.
Cell Cycle (Georgetown, Tex.)|March 15, 2014
Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic eventsRachael A McCloy, Samuel Rogers, C Elizabeth Caldon, et al.
Cancer Research|April 17, 2008
The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell aciniC Elizabeth Caldon, Alexander Swarbrick, Christine S L Lee, et al.
Drug Discovery Today|December 17, 2019
Targeting CDK2 in cancer: challenges and opportunities for therapySolomon Tadesse, Abel T Anshabo, Neil Portman, et al.
International Journal of Molecular Sciences|February 6, 2019
The Proliferative and Apoptotic Landscape of Basal-like Breast CancerSarah Alexandrou, Sandra Marie George, Christopher John Ormandy, et al.
Advances in Experimental Medicine and Biology|July 22, 2008
Cell cycle machinery: links with genesis and treatment of breast cancerAlison J Butt, C Elizabeth Caldon, Catriona M McNeil, et al.
Cell Cycle (Georgetown, Tex.)|January 18, 2013
Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1C Elizabeth Caldon, C Marcelo Sergio, Andrew Burgess, et al.
The Journal of Biological Chemistry|October 29, 2005
Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking proteinTilman Brummer, Daniel Schramek, Vanessa M Hayes, et al.
Cancers|August 23, 2020
Cyclin E2 Promotes Whole Genome Doubling in Breast CancerChristine Lee, Kristine J Fernandez, Sarah Alexandrou, et al.
Pageof 5